CANCER TRACK TM REPORT TO BE USED AND ACTED UPON BY A LEGALLY COMPETENT REGISTERED MEDICAL PRACTITIONER ONLY. DATAR GENETICS LIMITED (original) (raw)
Differential Modulation of Mitogen-activated Protein (MAP) Kinase/Extracellular Signal-related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor Receptor
David Moscatello
Journal of Biological Chemistry, 1995
View PDFchevron_right
Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF
Lark Wong
2001
View PDFchevron_right
Activation of the Ras/Mitogen-Activated Protein Kinase Pathway by Kinase-Defective Epidermal Growth Factor Receptors Results in Cell Survival but Not Proliferation
Normand Pouliot
1998
View PDFchevron_right
The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors
Fumin Chang
Pharmacology & Therapeutics, 2000
View PDFchevron_right
Role of Tyrosine Kinase Receptors in Growth Factor Mediated Signal Transduction, with Specific Reference to MAPK/Rasand p13k-Akt Containing Pathways in Oncogenesis: A Qualitative Database Review
Rajavarthani Sanjeev
American Journal of Molecular Biology, 2022
View PDFchevron_right
Molecular Mechanisms that Regulate Epidermal Growth Factor Receptor Inactivation
Brian Ceresa
Clinical medicine. Oncology, 2008
View PDFchevron_right
The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors
Carlos Arteaga
Seminars in Oncology, 2003
View PDFchevron_right
V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
C. Pratilas
Proceedings of the National Academy of Sciences, 2009
View PDFchevron_right
Epidermal growth factor receptor (EGFR) signaling in cancer
David Salomon
Gene, 2006
View PDFchevron_right
Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer
Alper Toker
Cancer, 2013
View PDFchevron_right
Mutational Analysis of the EGF Receptor Proto-Oncogene
J. Schlessinger
Cell to Cell Signals in Mammalian Development, 1989
View PDFchevron_right
Stimulation of Mitogenic Pathways through Kinase-Impaired Mutants of the Epidermal Growth Factor Receptor
Jonathan Ewald
Experimental Cell Research, 2001
View PDFchevron_right
Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041
Myron Toews, Debra Romberger
Molecular & Cellular Proteomics, 2009
View PDFchevron_right
Somatic mutations of the EGF receptor and their signal transducers affect the efficacy of EGF receptor-specific tyrosine kinase inhibitors
Noriko Gotoh
International journal of clinical and experimental pathology, 2011
View PDFchevron_right
EGFR Signaling and its inhibition by EGFR inhibitors in NSCLC
Rajvi Patel
International Journal of Applied Sciences and Biotechnology, 2014
View PDFchevron_right
EGFR Targeted Therapy: View from Biological Standpoint
Norman Sharpless
Cell Cycle, 2006
View PDFchevron_right
Emerging functions of theEGFRin cancer
Letizia Lanzetti
Molecular Oncology, 2017
View PDFchevron_right
The EGFR family: not so prototypical receptor tyrosine kinases
Mark Lemmon
2014
View PDFchevron_right
EGFR and NF-κB: partners in cancer
Alain Chariot
Trends in Molecular Medicine, 2015
View PDFchevron_right
Protein expression, gene amplification, epidermal growth factor receptor mutations and lung carcinoma
Zivka Eri
Vojnosanitetski pregled. Military-medical and pharmaceutical review, 2014
View PDFchevron_right
Comparison and analysis Receptor Tyrosine Kinases associated EGFR gene and its variants
JASH MATHEW
View PDFchevron_right
Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family
Steven Pelech
Journal of Biological Chemistry, 1993
View PDFchevron_right
Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy
Nikolas von Bubnoff
Clinical Cancer Research, 2009
View PDFchevron_right
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
Fumin Chang, Rich Franklin
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
View PDFchevron_right
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Bijay Jaiswal, Georgia Hatzivassiliou, Bonnie Liu, David Stokoe, Hartmut Koeppen, Kyung Song
Nature, 2010
View PDFchevron_right
Alterations in Genes of the EGFR Signaling Pathway and Their Relationship to EGFR Tyrosine Kinase Inhibitor Sensitivity in Lung Cancer Cell Lines
Yang Xie
PLOS One, 2009
View PDFchevron_right
Novel MEK1 Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung Adenocarcinoma
yan mardi
Cancer Research, 2008
View PDFchevron_right
Epidermal growth factor receptor (EGFR), KRAS, and BRAF mutations in lung adenocarcinomas: A study from India
prerna guleria
Current Problems in Cancer, 2018
View PDFchevron_right
Raf kinases in lung tumor development
Stefan Albert
Advances in Enzyme Regulation, 2003
View PDFchevron_right
Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation
Ana Isabel Cosgaya
PLOS ONE, 2015
View PDFchevron_right
EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism
Yaara Zwang
Oncogene, 2010
View PDFchevron_right
Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics
Nandini Nair
Molecular and cellular biology, 1992
View PDFchevron_right